Your browser doesn't support javascript.
Evidence of SARS-CoV-2 reinfection within the same clade in Ecuador: A case study.
Sevillano, Gabriela; Ortega-Paredes, David; Loaiza, Karen; Zurita-Salinas, Camilo; Zurita, Jeannete.
  • Sevillano G; Unidad de Investigaciones en Biomedicina, Zurita and Zurita Laboratorios, Quito, Ecuador.
  • Ortega-Paredes D; Unidad de Investigación en Enfermedades Transmitidas por Alimentos y Resistencia a los Antimicrobianos (UNIETAR), Facultad de Veterinaria, Universidad Central del Ecuador, Quito, Ecuador.
  • Loaiza K; Research Unit, Life Science Initiative, Quito, Ecuador.
  • Zurita-Salinas C; Unidad de Investigaciones en Biomedicina, Zurita and Zurita Laboratorios, Quito, Ecuador.
  • Zurita J; Unidad de Investigaciones en Biomedicina, Zurita and Zurita Laboratorios, Quito, Ecuador; Facultad de Medicina, Pontificia Universidad Católica del Ecuador, Quito, Ecuador. Electronic address: jzurita@zuritalaboratorios.com.
Int J Infect Dis ; 108: 53-56, 2021 Jul.
Article in English | MEDLINE | ID: covidwho-1351683
ABSTRACT

OBJECTIVES:

To date, reported SARS-CoV-2 reinfection cases are mainly from strains belonging to different clades. As the pandemic advances, a few lineages have become dominant in certain areas leading to reinfections by similar strains. Here, we report a reinfection case within the same clade of the initial infection in a symptomatic 28-year-old-male in Quito-Ecuador.

METHODS:

Infection was detected by reverse transcription-polymerase chain reaction, and immune response evaluated by antibody testing. Whole-genome sequencing was performed and phylogenetic analysis conducted to determine relatedness.

RESULTS:

Both the infection and the reinfection strains were assigned as Nextstrain 20B, Pangolin lineage B.1.1 and GISAID clade O. Our analysis indicated 4-6 fold more nucleotide changes than are expected for reactivation or persistence compared with the natural rate of SARS-CoV-2 mutation (∼2-3 nucleotide changes per month), thus supporting reinfection. Furthermore, approximately 3 months after the second infection, COVID-19 antibodies were not detectable in the patient, suggesting potential vulnerability to a third infection.

CONCLUSIONS:

Our results showed evidence of SARS-CoV-2 reinfection within the same clade in Ecuador, indicating that previous exposure to SARS-CoV-2 does not guarantee immunity in all cases.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Case report / Experimental Studies / Observational study / Randomized controlled trials Topics: Long Covid Limits: Adult / Humans / Male Country/Region as subject: South America / Ecuador Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: J.ijid.2021.04.073

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: SARS-CoV-2 / COVID-19 Type of study: Case report / Experimental Studies / Observational study / Randomized controlled trials Topics: Long Covid Limits: Adult / Humans / Male Country/Region as subject: South America / Ecuador Language: English Journal: Int J Infect Dis Journal subject: Communicable Diseases Year: 2021 Document Type: Article Affiliation country: J.ijid.2021.04.073